Metal-Regulated Pasteurella Proteins for Cross-Serotype Vaccine Protection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current vaccines against Pasteurella multocida, which cause avian diseases like fowl cholera, do not provide cross-protection across different serotypes due to variations in iron-acquisition systems among bacterial strains, limiting their effectiveness in heterologous challenges.

Innovation Solution

Compositions comprising specific metal-regulated proteins from Pasteurella multocida, isolated under iron-restricted conditions, are used to vaccinate animals, providing heterologous protection against multiple serotypes by targeting common iron-acquisition mechanisms.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If current vaccines against Pasteurella multocida are used, then protection against specific serotypes is achieved, but cross-protection across different serotypes is not provided

Engineering Contradiction:
Improveprotection effectivenessVSAvoidcross-protection across serotypes
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The vaccine composition uses metal-regulated proteins that are universally expressed across different Pasteurella multocida serotypes. These proteins perform the same protective function against multiple serotypes (1, 3, 4, and other heterologous strains) rather than being specific to a single serotype, achieving multi-functionality in vaccine protection

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The invention changes the parameter of vaccine antigen selection from serotype-specific surface proteins to metal-regulated proteins that are conserved across serotypes. By targeting proteins regulated by metal ions (iron, zinc, copper) that are essential for bacterial survival across all serotypes, the vaccine achieves broad-spectrum protection while maintaining high reliability against challenge infections

Inventive Principle:
Principle #35Parameter changes

2Reliability

If vaccines target serotype-specific antigens, then high protection against homologous strains is achieved, but heterologous protection against different serotypes is limited

Engineering Contradiction:
Improvehomologous protectionVSAvoidheterologous protection
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The invention extracts and isolates specifically the metal-regulated proteins from Pasteurella multocida that are conserved across different serotypes. By taking out these specific proteins (encoded by genes such as fur, znuA, cueO) that are essential for bacterial metal acquisition and are universally present, the vaccine achieves both homologous and heterologous protection without being constrained by serotype-specific variations

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The metal-regulated proteins serve as universal antigens that trigger immune responses effective against multiple serotypes. These proteins perform the dual function of being essential for bacterial survival (making them consistent targets) and being conserved across serotypes (enabling cross-protection), thus achieving universality in vaccine efficacy

Inventive Principle:
Principle #6Universality (Multi-functionality)

Data Source

PatentUS20250255950A1Proteins and immunizing compositions containing pasteurella proteins and methods of use
Publication Date: 2025.08.14 UIPCO LLC
  • US20250255950A1 patent drawing
  • US20250255950A1 patent drawing
  • US20250255950A1 patent drawing

AI summary

The present invention provides isolated proteins isolatable from a Pasteurella spp. such as P. multocida. Also provided by the present invention are compositions that include one or more of the proteins, and methods for making and methods for using the proteins.